CDAK
Income statement / Annual
Last year (2021), Codiak BioSciences, Inc.'s total revenue was $22.94 M,
an increase of 686.79% from the previous year.
In 2021, Codiak BioSciences, Inc.'s net income was -$41.63 M.
See Codiak BioSciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$22.94 M |
$2.92 M |
$388,000.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$22.94 M
|
$2.92 M
|
$388,000.00
|
$0.00
|
| Gross Profit Ratio |
1
|
1
|
1
|
0
|
| Research and Development Expenses |
$64.86 M
|
$73.98 M
|
$59.50 M
|
$36.54 M
|
| General & Administrative Expenses |
$27.63 M
|
$19.85 M
|
$21.04 M
|
$9.90 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$27.63 M
|
$19.85 M
|
$21.04 M
|
$9.90 M
|
| Other Expenses |
$0.00
|
$906,000.00
|
$992,000.00
|
$0.00
|
| Operating Expenses |
$92.48 M
|
$93.83 M
|
$80.54 M
|
$46.44 M
|
| Cost And Expenses |
$92.48 M
|
$93.83 M
|
$80.54 M
|
$46.44 M
|
| Interest Income |
$22,000.00
|
$253,000.00
|
$1.50 M
|
$1.36 M
|
| Interest Expense |
$2.70 M
|
$1.91 M
|
$300,000.00
|
$0.00
|
| Depreciation & Amortization |
$6.42 M
|
$1.16 M
|
$5.26 M
|
$1.73 M
|
| EBITDA |
-$61.33 M |
-$89.76 M |
-$74.89 M |
-$42.82 M |
| EBITDA Ratio |
-2.67
|
-30.79
|
-193.01
|
0
|
| Operating Income Ratio |
-3.03
|
-31.19
|
-206.58
|
0
|
| Total Other Income/Expenses Net |
$32.39 M
|
-$747,000.00
|
$2.19 M
|
$1.90 M
|
| Income Before Tax |
-$37.16 M
|
-$91.67 M
|
-$77.96 M
|
-$44.54 M
|
| Income Before Tax Ratio |
-1.62
|
-31.45
|
-200.93
|
0
|
| Income Tax Expense |
$4.48 M
|
-$2.73 M
|
$1.29 M
|
$1.90 M
|
| Net Income |
-$41.63 M
|
-$88.93 M
|
-$79.25 M
|
-$44.54 M
|
| Net Income Ratio |
-1.82
|
-30.51
|
-204.26
|
0
|
| EPS |
-1.91 |
-14.04 |
-6.03 |
-3.4 |
| EPS Diluted |
-1.91 |
-14.04 |
-6.03 |
-3.4 |
| Weighted Average Shares Out |
$21.79 M
|
$6.33 M
|
$13.13 M
|
$13.11 M
|
| Weighted Average Shares Out Diluted |
$21.79 M
|
$6.33 M
|
$13.13 M
|
$13.11 M
|
| Link |
|
|
|
|
